1517 Fund
Yale Medical School
Clinical Partnerships
Users
We're proud to be backed by the 1517 Fund and a network of experienced angel investors who believe in our mission to revolutionize speech therapy.
We're collaborating with leading researchers at Yale Medical School to ensure our solutions are grounded in cutting-edge clinical research and best practices.
Our app is now deployed and available on the App Store, bringing our innovative speech therapy solutions to users worldwide.
A comprehensive approach to stuttering treatment combining cutting-edge hardware detection with AI-powered therapy

Our advanced EEG device detects early neurological patterns associated with stuttering causes. Developed in collaboration with Yale Medical School researchers, it provides real-time brain activity monitoring to identify stuttering triggers and patterns before they manifest in speech.

Our AI-powered mobile application delivers personalized stuttering treatment through adaptive exercises and real-time feedback. Available on the App Store, Fluent Minds uses machine learning to tailor therapy sessions to each user's unique needs and progress.
Together, our hardware and software create a closed-loop system that detects stuttering patterns and delivers targeted AI-powered treatment, revolutionizing how stuttering is managed and treated.
Meet the individuals driving innovation in stuttering treatment